GenAI leadership CapeStart is expanding its AI Center of Excellence with a new India office to attract generative AI professionals, signaling a strong investment in leadership and capability in GenAI that can be leveraged to cross-sell AI-driven transformations, data services, and integrated AI platforms.

Life sciences focus The company emphasizes life sciences, healthcare, MedTech, and regulatory workflows with MadeAi, a GenAI platform for literature review and evidence workflows, presenting opportunities to upsell AI-assisted literature review, regulatory submissions support, and data synthesis services to pharma and biotech clients.

Platform sales MadeAi and related AI platforms are core offerings that accelerate content and data synthesis; selling through a platform approach to multiple life sciences and clinical research customers can expand contract scope beyond services into licensed solutions and ongoing platform adoption.

Awarded credibility CapeStart has earned recognitions such as Stevie Awards and HRWorld employee experience accolades, which can be leveraged in outreach to enterprise buyers seeking proven partners with validated outcomes and strong workplace culture to reduce procurement risk.

Global delivery reach With delivery centers in India and presence across the Middle East and Asia, CapeStart can position itself as a nearshore/offshore partner to US-based clients seeking scalable AI, data, and digital engineering programs with multi-regional delivery and governance.